Rosetta Genomics, Ltd. (NASDAQ: ROSG), a company in the business of developing and commercializing MicroRNA-based and other molecular diagnostics, recently had its ‘Buy’ rating restated by Aegis Capital Corp. (http://dtn.fm/l0Yk0) with a price target of $3.50 per share. This was … Continue reading →

Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company, on January 4 announced it had completed enrollment for its Phase 3 Apollo Pivotal Efficacy Trials of oliceridine for moderate to severe pain. Oliceridine (TRV 130) is Trevena’s lead product candidate. … Continue reading →

Jaguar Animal Health, Inc. (NASDAQ: JAGX), a company in the business of developing and commercializing gastrointestinal products for companion animals, horses, and production animals, recently had its company outlook updated by Aegis Capital Corp. (http://dtn.fm/Phj8l). The company has been offered … Continue reading →

Earlier this week, Bovie Medical Corporation (NYSE MKT: BVX), a leading developer of medical devices and supplies, announced its plans to participate in the 9th Annual Biotech Showcase Conference, which is set to take place at the Hilton San Francisco … Continue reading →

One of the biggest problems facing ecommerce – online fashion retailers, in particular – is high return rates due to the fact that purchased products aren’t always a good fit. This can apply to all kinds of items, but clothing … Continue reading →

Remedies for pain have progressed beyond the one recommended in Shakespeare’s Romeo and Juliet, where the renowned playwright wrote, “One pain is lessened by another; catch some new infection… and the poison of the old one will die.” Today, a … Continue reading →

Rennova Health, Inc. (NASDAQ: RNVA, RNVAX), a vertically integrated public holding company serving the health care sector, focuses on offering comprehensive single-source solutions to health care providers ranging from diagnostic laboratory testing to technology solutions, revenue cycle management and financial … Continue reading →

An innovative potential treatment for hepatic encephalopathy created by Ocera Therapeutics, Inc. (NASDAQ: OCRX) is a unique product on an under-served market, and if clinical trials are successful, it could become a major source of success and profitability for the … Continue reading →

How does a start-up venture capital-backed company grow its revenues to nearly a billion dollars in the global spine industry in less than two decades? By developing a competitive advantage in Speed of Innovation® and Absolute Responsiveness®, two concepts that … Continue reading →

Nano Dimension Ltd. (NASDAQ: NNDM) is the holding company for Nano Dimension Technology Ltd., a company in the business of researching, developing, and manufacturing three-dimensional (3D) printers for printed circuit boards (PCBs). The company also develops nano ink materials and … Continue reading →